日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes

MK-4256是一种强效的SSTR3拮抗剂,其作为2型糖尿病潜在治疗方法的发现

He, Shuwen; Ye, Zhixiong; Truong, Quang; Shah, Shrenik; Du, Wu; Guo, Liangqin; Dobbelaar, Peter H; Lai, Zhong; Liu, Jian; Jian, Tianying; Qi, Hongbo; Bakshi, Raman K; Hong, Qingmei; Dellureficio, James; Pasternak, Alexander; Feng, Zhe; deJesus, Reynalda; Yang, Lihu; Reibarkh, Mikhail; Bradley, Scott A; Holmes, Mark A; Ball, Richard G; Ruck, Rebecca T; Huffman, Mark A; Wong, Frederick; Samuel, Koppara; Reddy, Vijay B; Mitelman, Stan; Tong, Sharon X; Chicchi, Gary G; Tsao, Kwei-Lan; Trusca, Dorina; Wu, Margaret; Shao, Qing; Trujillo, Maria E; Eiermann, George J; Li, Cai; Zhang, Bei B; Howard, Andrew D; Zhou, Yun-Ping; Nargund, Ravi P; Hagmann, William K

Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.

新型口服微管蛋白聚合抑制剂 IMC-038525 的抗肿瘤活性

Tuma Maria Carolina, Malikzay Asra, Ouyang Xiaohu, Surguladze David, Fleming James, Mitelman Stan, Camara Margarita, Finnerty Bridget, Doody Jacqueline, Chekler Eugene L P, Kussie Paul, Tonra James R